Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-6 of 6
Keywords: Maintenance therapy
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302
Available to PurchaseSubject Area:
Oncology
Satoshi Ikeda, Hiroshige Yoshioka, Toshihiko Kaneda, Toshihide Yokoyama, Takashi Niwa, Naoyuki Sone, Tadashi Ishida, Mitsunori Morita, Hiromi Tomioka, Chihito Komaki, Masataka Hirabayashi, Yoshinori Hasegawa, Tetsuo Noguchi, Yasutaka Nakano, Chikara Sakaguchi, Kenichi Yoshimura, Toyohiro Hirai
Journal:
Oncology
Oncology (2019) 97 (6): 327–333.
Published Online: 14 August 2019
... Background: There has been no study so far on gemcitabine continuous maintenance therapy targeting only squamous non-small-cell lung cancer (NSCLC) patients. This study aimed to assess the efficacy and safety of cisplatin plus gemcitabine followed by maintenance gemcitabine for chemotherapy- naïve Japanese...
Journal Articles
The Evolving Arena of Ovarian Cancer Maintenance Therapy
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2019) 97 (4): 202–205.
Published Online: 09 July 2019
...Maurie Markman Based on the results of several phase 3 randomized trials, “maintenance therapy” (prolonged treatment after an initial response to cytotoxic chemotherapy) has assumed a critical role in the routine care of advanced epithelial ovarian cancer. While earlier data had provided support...
Journal Articles
Maintenance Therapy with Biweekly Cetuximab: Optimizing Schedule Can Preserve Activity and Improves Compliance in Advanced Head and Neck Cancer
Available to PurchaseSubject Area:
Oncology
Raffaele Addeo, Liliana Montella, Amerigo Mastella, Bruno Vincenzi, Salvatore Mazzone, Filippo Ricciardiello, Salvatore Del Prete
Journal:
Oncology
Oncology (2018) 95 (6): 353–359.
Published Online: 05 September 2018
... subjects included fatigue, rash, and hypomagnesemia. Conclusion: Maintenance therapy with simplified biweekly cetuximab is a convenient, effective, and well-tolerated regimen in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. [email protected] 2 07 2018...
Journal Articles
Subject Area:
Oncology
Suayib Yalcin, Ruchan Uslu, Faysal Dane, Ugur Yilmaz, Nurullah Zengin, Evin Buyukunal, Suleyman Buyukberber, Celalettin Camci, Orhan Sencan, Sadettin Kilickap, Fatih Ozdener, Duygu Cevik
Journal:
Oncology
Oncology (2013) 85 (6): 328–335.
Published Online: 12 November 2013
...Suayib Yalcin; Ruchan Uslu; Faysal Dane; Ugur Yilmaz; Nurullah Zengin; Evin Buyukunal; Suleyman Buyukberber; Celalettin Camci; Orhan Sencan; Sadettin Kilickap; Fatih Ozdener; Duygu Cevik Objective: It was the aim of this study to evaluate maintenance therapy with bevacizumab + capecitabine...
Journal Articles
Maintenance or Consolidation Therapy in Advanced Ovarian Cancer
Available to PurchaseSubject Area:
Oncology
Journal:
Oncology
Oncology (2007) 70 (5): 315–324.
Published Online: 15 January 2007
...) 75% and median survival ranged from 26 months for patients with bulky residual disease to more than 60 months for patients with small volume disease [ 4,5,6 ]. Unfortunately, 75% of the CR patients experience disease recurrence [ 4,5,6,7 ]. An effective consolidation or maintenance therapy that would...
Journal Articles
Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer
Available to PurchaseSubject Area:
Oncology
Gianfilippo Bertelli, Ornella Garrone, Laura Bertolotti, Marcella Occelli, Serafino Conforti, Nicola Marzano, Antonio Febbraro, Paolo Carlini, Christina Liossi, Lucia Del Mastro, Robert C.F. Leonard
Journal:
Oncology
Oncology (2005) 68 (4-6): 364–370.
Published Online: 17 August 2005
... clinicians in advanced breast cancer patients with potentially hormone-sensitive tumors, although there are insufficient evidences in the literature to support this practice. We investigated the effects of the third-generation aromatase inhibitor letrozole as a maintenance therapy in postmenopausal patients...